Disease Info Card

Beckwith-wiedemann Syndrome

Information about Beckwith-wiedemann Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Beckwith-wiedemann Syndrome

Most recent studies have shown that Beckwith-wiedemann Syndrome shares some biological mechanisms with angelman-syndrome, carcinoma, congenital-abnormality, congenital-exomphalos, congenital-hemihypertrophy, congenital-omphalocele, cytogenetic-abnormality, gigantism, growth-disorders, hepatoblastoma, hyperplasia, hypoglycemia, kidney-neoplasm, macroglossia, malignant-neoplasms, neoplasms, nephroblastoma, prader-willi-syndrome, russell-silver-syndrome, uniparental-disomy.

Among the many pathways, these few ones have gauged particular interests from scientists studying Beckwith-wiedemann Syndrome, and have been seen in publications frequently: Cell Cycle, Cell Differentiation, Cell Division, Cell Growth, Cell Proliferation, Demethylation, Dna Methylation, Dna Replication, Excretion, Fertilization, Genetic Imprinting, Glycosylation, Insulin Secretion, Localization, Methylation, Mitotic Recombination, Oncogenesis, Ossification, Pathogenesis, Secretion

Quite a number of genes have been found to play important roles in Beckwith-wiedemann Syndrome, such as AGRP, ART2B, CDKN1C, CDKN2B, CIB2, CORO1A, IGF2, INS, KCNQ1, MRPL28, NXT1, SUB1, UROD, WT1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.